ANALYTICAL AND BIOMEDICAL STUDIES OF ANTIBIOTICS: MODERN APPROACHES TO ASSESSING EFFICACY, SAFETY, AND ANTIMICROBIAL RESISTANCE

Authors

Keywords:

antibiotics; antimicrobial resistance; analytical chemistry; microbiological susceptibility; chromatography; mass spectrometry; pharmacokinetics; drug safety; molecular diagnostics; antimicrobial stewardship

Abstract

Antibiotics have transformed the management of bacterial infections and remain indispensable in modern medicine. Their clinical value, however, is increasingly threatened by antimicrobial resistance, inappropriate use, variable drug exposure, and the circulation of resistant bacterial populations. Reliable antibiotic assessment therefore requires a combination of pharmaceutical, microbiological, pharmacological, and molecular approaches. This review examines contemporary analytical and biomedical methods used to evaluate antibiotic quality, antimicrobial efficacy, safety, pharmacokinetic behavior, and resistance mechanisms. Chromatographic and spectroscopic techniques are considered for identification, quantification, purity assessment, stability testing, and analysis of metabolites. Microbiological approaches, including disk diffusion, broth dilution, minimum inhibitory concentration and minimum bactericidal concentration testing, are discussed as essential tools for determining phenotypic susceptibility. Molecular approaches, including polymerase chain reaction and sequencing, provide additional information about resistance-associated genes and mechanisms. The reviewed evidence supports an integrated model in which pharmaceutical analysis, susceptibility testing, and molecular diagnostics are interpreted together. Such integration can strengthen quality assurance, improve understanding of treatment response, support antimicrobial stewardship, and enhance surveillance of resistance. Further development of sensitive, standardized, rapid, and accessible analytical platforms is important for improving antibiotic research and for responding to the continuing global challenge of antimicrobial resistance.

References

1.World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.

2.World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015.

3.Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399:629–655.

4.Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. Wayne, PA: CLSI.

5.European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints and antimicrobial susceptibility testing guidance. EUCAST.

6.Ventola CL. The antibiotic resistance crisis: part 1 and part 2. Pharmacy and Therapeutics. 2015;40:277–283; 344–352.

7.Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clinic Proceedings. 2011;86:156–167.

8.Silver LL. Challenges of antibacterial discovery. Clinical Microbiology Reviews. 2011;24:71–109.

9.Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. New England Journal of Medicine. 2013;368:299–302.

10.Rather IA, Kim BC, Bajpai VK, Park YJ. Self-medication and antibiotic resistance: crisis, current challenges, and prevention. Saudi Journal of Biological Sciences. 2017;24:808–812.

11.Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and Global Health. 2015;109:309–318.

12.Holmes AH, Moore LSP, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 2016;387:176–187.

13.McEwen SA, Collignon PJ. Antimicrobial resistance: a one health perspective. Microbiology Spectrum. 2018;6.

14.Roca I, Akova M, Baquero F, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes and New Infections. 2015;6:22–29.

15.World Health Organization. WHO report on surveillance of antibiotic consumption: 2016–2018 early implementation. Geneva: WHO.

16.Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clinical Microbiology Reviews. 2007;20:391–408.

17.Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clinical Infectious Diseases. 2009;49:1749–1755.

18.Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clinical Chemistry. 2015;61:100–111.

Published

2026-09-25